ReviewThe journal of prevention of Alzheimer's disease2026
Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications.
Jeffrey L Cummings et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.